723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster III

Characterization of patients with restrictive patterns of lung disease following allogeneic hematopoietic stem cell transplantation

Letermovir prophylaxis for cytomegalovirus and immune reconstitution after allogeneic hematopoietic stem cell transplantation A single center real world study

Safety and efficacy of blinatumomab for EBV viremia and PTLD following allogeneic hematopoietic stem cell transplantation

Multicenter propensity score matched study on allogeneic stem cell transplantation in adult sickle cell disease Comparison of donor vs no donor outcomes

Single center retrospective analysis of maribavir in the treatment of refractory and drug intolerant cytomegalovirus viremia and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation

Persistent symptom burden and unmet needs in long term survivors of allogeneic hematopoietic cell transplantation An analysis using the MD anderson symptom inventory MDASI BMT

Clinical features and prognostic model for adenovirus infection following allogeneic hematopoietic stem cell transplantation Insights from a Chinese cohort

Clinical efficacy of allogeneic hematopoietic stem cell transplantation in infant acute leukemia

Old mismatched donors are associated with inferior outcomes after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndrome but not in Acute Myeloid Leukemia

The limited impact of preexisting rheumatologic diseases on outcomes after allogeneic hematopoietic stem cell transplantation A nationwide Propensity–Matched analysis

A longitudinal study on the impact of hematopoietic stem cell transplantation on sickle cardiomyopathy

Allo HSCT mitigates the prognostic differences between bZIP and non bZIP CEBPA mutations in AML A long term follow up study of lu daopei hospital

Factors associated with the development of second primary malignancies after allogeneic stem cell hematopoietic transplantation no association with In Vivo T cell depletion

Outcomes and risk factors of second allogeneic hematopoietic stem cell transplantation in patients with relapsed hematological malignancy after first transplantation

Real world outcomes with blinatumomab as a bridging therapy for allogeneic hematopoietic stem cell transplantation in relapsed refractory or measurable residual disease positive B cell acute lymphoblastic leukemia A CIBMTR database analysis

Nelarabine treatment before allogeneic stem cell transplantation was associated with an increased risk of neurological adverse events in patients with T ALL lbl A retrospective study of the kanto study group for cell therapy

Living the recovery One year qol outcomes for patients receiving ptcy gvhd prophylaxis on the access clinical trial

Spatial asymmetry of blasts in bone marrow after hematopoietic stem cell transplantation for AML MDS

Impact of infectious complications on outcomes after allogeneic hematopoietic stem cell transplantation in elderly patients A geth TC study

Incidence and risk factors for CNS relapse in adult ALL after allogeneic hematopoietic cell transplant